Thomas Ebeling

Thomas Ebeling

Director/Board Member presso CULLINAN THERAPEUTICS, INC.

Patrimonio netto: 1 M $ in data 31/03/2024

65 anni
Health Technology
Finance
Consumer Services

Profilo

Thomas Ebeling is the founder of Betterlifehealthcare Ltd.
(founded in 2015), Heilpflanzenwohl AG (founded in 2016), and Te Convest AG (founded in 2018).
He is currently the Chairman of the Fund at Remagine Media Ventures, Chairman at Galderma Group AG, Director at Sivantos, Inc. (Canada), Director at Galderma Holding SA, Director at ClearVAT AG, Director at Triangle Holding III SARL, Director at SHL Medical AG, Director at Orna Therapeutics, Inc. (since 2022), Independent Director at Cullinan Oncology, Inc. (since 2017), Advisor at MPM BioImpact, Inc, Member-Supervisory Board at Schwandorfer Rohstoff- und Recycling GmbH, and Board Member & Strategic Advisor at Moonfare GmbH (since 2018).
His former positions include Chairman-Executive Board & CEO at ProSiebenSat.1 Media SE (2009-2017), Chief Executive Officer-Pharmaceuticals Division at Novartis AG (2000-2007), Chief Executive Officer at Novartis Pharmaceuticals Corp.
(2000-2007), Chief Executive Officer at Novartis Consumer Health, Inc. (2007-2008), Chief Executive Officer at Novartis Nutrition GmbH (1998-2000), Chairman at Auris Luxembourg III SA, Chairman-Supervisory Board at Apleona GmbH, Chairman-Supervisory Board at Ostbayerische Verwertungs- und Energieerzeugungsgesellschaft, Director at Idenix Pharmaceuticals LLC, Independent Director at Lonza Group AG (2013-2017), Director-National Sales & Franchise at PepsiCo Deutschland GmbH (1994-1996), Director at EQT AB, Independent Non-Executive Director at Ocean Outdoor Ltd.
(2018-2021), Independent Director at Cullinan Oncology LLC, Member-Supervisory Board at QIAGEN NV, and Member-Supervisory Board at Bayer AG (2012-2019).
He holds an undergraduate degree from the University of Hamburg (1986).

Partecipazioni note in società pubbliche

SocietàDataNumero di azioniValorizzazioneData di valutazione
15/02/2024 67 504 ( 0.16% ) 1 M $ 31/03/2024
28/02/2023 0 ( -.--% ) - $ 31/03/2024

Posizioni attive di Thomas Ebeling

SocietàPosizioneInizio
CULLINAN THERAPEUTICS, INC. Director/Board Member 01/08/2017
Remagine Media Ventures/Germany/ Chairman -
Director/Board Member -
Director/Board Member -
Director/Board Member 09/03/2022
Consultant / Advisor -
Director/Board Member -
Director/Board Member 01/01/2016
Triangle Holding III SARL Director/Board Member -
░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
Tutte le posizioni attive di Thomas Ebeling

Precedenti posizioni note di Thomas Ebeling

SocietàPosizioneFine
░░░░░ ░░░░░░░ ░░░░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░░░ ░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░░░ ░░░░░ ░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░░░░░░░░░░░░ ░░░░░ ░░ ░░░░░ ░░░░░░░░░ ░░░░░░░ ░░░░░░░░░░
░░░░░░░░ ░░░░░░░░ ░░░░░░░ ░░░░ ░░░░░ ░░░░░░░░░ ░░░░░░░ ░░░░░░░░░░
Vedi nel dettaglio l'esperienza di Thomas Ebeling

Formazione di Thomas Ebeling

University of Hamburg Undergraduate Degree

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Thomas Ebeling

Relazioni

100 +

Relazioni di 1° grado

32

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Società quotate in Borsa6
QIAGEN N.V.

Health Technology

BAYER AG

Health Technology

PROSIEBENSAT.1 MEDIA SE

Consumer Services

NOVARTIS AG

Health Technology

LONZA GROUP AG

Health Technology

EQT AB

Finance

Aziende private25

Health Technology

Finance

Consumer Non-Durables

Health Technology

Health Technology

Consumer Non-Durables

Retail Trade

Health Technology

Finance

Commercial Services

Commercial Services

Finance

Finance

Industrial Services

Transportation

Heilpflanzenwohl AG

Te Convest AG

Finance

Triangle Holding III SARL

Health Technology

Health Technology

Cullinan Oncology, Inc.

Remagine Media Ventures/Germany/

Finance

Novartis Nutrition GmbH

Health Technology

Vedi le connessioni aziendali
  1. Borsa valori
  2. Insiders
  3. Thomas Ebeling